Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Medical Faculty of Heidelberg, University of Heidelberg, Heidelberg, Germany.
Clin Transl Gastroenterol. 2018 Jul 6;9(7):168. doi: 10.1038/s41424-018-0035-2.
To systematically investigate and directly compare, for the first time, the sample stability of a large number of quantitative fecal immunochemical tests (FITs) at different storage conditions.
Stool samples were obtained from participants of the German screening colonoscopy program between 2005 and 2010. After an initial FIT-based hemoglobin (Hb) measurement, stool samples were kept frozen at -80 °C until analysis. Twenty randomly selected participants with initial measurements ranging from 10 to 100 μg Hb/g feces were included. Ten quantitative FITs were investigated in parallel. A defined stool amount was extracted using each manufacturer's brand-specific fecal sampling device and stored at 5 °C, 20 °C, and 35 °C, respectively. After 1, 4, 5, and 7 days, the samples were analyzed blinded. Median fecal Hb concentrations and positivity rates were calculated.
Mean age of the participants was 67 years (range: 56-80 years) and 60% were male. The most advanced finding at screening colposcopy was advanced adenoma in five and non-advanced adenoma in eight cases. Hyperplastic polyps were found in two participants and five participants were without any findings. At 5 °C storage temperature, almost all FITs showed fairly stable results throughout the 7-day observation period. At 20 °C, most FITs still showed fairly stable results over 4 days, whereas positivity rates significantly declined from day 4 on for most FITs at 35 °C. Major differences regarding the sample stability between FITs were observed.
FIT-specific Hb decay according to ambient temperature and time period between sampling and test evaluation requires careful consideration in the design of FIT-based screening programs.
首次系统地调查和直接比较大量定量粪便免疫化学检测(FIT)在不同储存条件下的样本稳定性。
粪便样本取自 2005 年至 2010 年间参加德国筛查结肠镜检查计划的参与者。在初始 FIT 基于血红蛋白(Hb)测量后,粪便样本在-80°C 下冷冻保存直至分析。纳入了 20 名初始测量值在 10 至 100μg Hb/g 粪便范围内的随机选择的参与者。平行研究了 10 种定量 FIT。使用每个制造商的特定粪便采样设备提取一定量的粪便,分别在 5°C、20°C 和 35°C 下储存。在 1、4、5 和 7 天后,对样本进行了盲法分析。计算中位数粪便 Hb 浓度和阳性率。
参与者的平均年龄为 67 岁(范围:56-80 岁),60%为男性。筛查结肠镜检查中最先进的发现是 5 例高级别腺瘤和 8 例非高级别腺瘤。在 2 名参与者中发现了增生性息肉,5 名参与者没有任何发现。在 5°C 储存温度下,几乎所有的 FIT 在 7 天观察期内都表现出相当稳定的结果。在 20°C 时,大多数 FIT 在 4 天内仍表现出相当稳定的结果,而在 35°C 时,大多数 FIT 的阳性率从第 4 天开始显著下降。观察到 FIT 之间样本稳定性存在显著差异。
根据环境温度和采样与测试评估之间的时间间隔,FIT 特异性 Hb 衰减需要在 FIT 为基础的筛查计划的设计中谨慎考虑。